Tradestie Institutional Equity Comparison Engine

VIVS vs DDD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DDD Overall Edge

DDD Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to 3D Systems Corporation (DDD) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VIVS trades at N/M Forward P/E with -10117.0% operating margin (-51.4% YoY revenue) versus DDD at 22.5x Forward P/E and -15.1% operating margin (+8.8% YoY). In options structure, VIVS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against DDD sits in BREAKDOWN (32nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner DDD
VIVS N/M vs DDD 22.5x Fwd P/E
Growth & Margin Winner DDD
Op Margin -10117.0% vs -15.1% ยท YoY -51.4% vs +8.8%
Momentum & Technical Winner DDD
1Y -87.0% vs -28.9% ยท 52W Pos 5% vs 6%
Options & Structure Winner DDD
BREAKDOWN (N/A IV) vs BREAKDOWN (32nd %ile IV)
VIVS NASDAQ
VivoSim Labs, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.29
+142.92% 1D
Market Cap $2.4M
1M Return +64.69%
1Y Return -86.99%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 5.0 Fund 38.0 Flow 50.0 Mom 50.0
DDD NYSE
3D Systems Corporation
Services-Prepackaged Software
$1.48
+7.25% 1D
Market Cap $250.2M
1M Return -50.99%
1Y Return -28.85%
Forward P/E 22.5x
Unified AI Score
57.8 / 100 HOLD
Tech 60.0 Fund 62.0 Flow 70.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VIVS -86.99% DDD -28.85% Spread: +58.14 pp (DDD Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period VIVS Revenue DDD Revenue VIVS Op. Margin DDD Op. Margin Margin Edge
FY2019 $0M $640M -882.4% -9.0% DDD
FY2020 $0M $560M -977.9% -21.3% DDD
FY2021 N/A $620M N/A -5.4% DDD
FY2022 $0M $540M -765.3% -21.7% DDD
FY2023 $0M $490M -4792.2% -83.2% DDD
FY2024 $0M $440M -13840.4% -63.0% DDD
FY2025 $0M $390M -8761.1% -24.8% DDD
FY2026 $0M N/A -8768.7% N/A VIVS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VIVS (1) vs DDD (8)
Institutional Metric VIVS DDD Criterion Row Winner
Market Capitalization Scale $2.4M $250.2M Larger Scale DDD
Trailing P/E Ratio Valuation N/M 22.5x Lower Multiple DDD
Forward P/E Ratio Valuation N/M 22.5x Lower Multiple DDD
Revenue Growth (YoY) Growth -51.4% +8.8% Higher Growth DDD
Operating Margin (TTM) Profitability -10117.0% -15.1% Higher Margin DDD
Net Profit Margin Profitability 0.0% -17.8% Higher Margin VIVS
Return on Equity (ROE) Capital Efficiency -343.1% -30.0% Higher ROE DDD
52-Week Range Position Momentum 5% ($0โ€“$3) 6% ($1โ€“$4) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 0.83ฮฒ ยท 480% Vol 3.24ฮฒ ยท 140% Vol Lower Realized Risk DDD
Unified Institutional Score Composite Signal 36.8 / 100 (SELL) 57.8 / 100 (HOLD) Higher Composite DDD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VIVS vs DDD Buy Guide
VIVS BREAKDOWN
73d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VIVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DDD BREAKDOWN
119d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 32nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live DDD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VIVS nor DDD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.